It took nearly a quarter century for Regeneron Pharmaceuticals Inc. to bring a commercially successful drug onto the market. Now the company is trying to prove it can strike gold twice.. The Tarrytown, N.Y., drug maker, led by Chief Executive Leonard Schleifer, is racing to bring a new type of cholesterol-lowering treatment, thought to be worth billions in annual sales, onto the market before its competitors.. Regeneron's...
  